Lupin Diagnostics Expands Presence in South India with New Regional Reference Laboratory in Hyderabad

Global pharma major Lupin Limited (Lupin) announced today the launch of its new Regional Reference Laboratory in Hyderabad, Telangana. This expansion of Lupin Diagnostics' network is part of the company's strategy to build and strengthen its presence in South India. This regional reference laboratory adds to Lupin Diagnostics' existing network of 380+ LupiMitra collection centers and 23 laboratories across India.

Lupin Diagnostics is committed to making preventive quality healthcare accessible and affordable to all. Through the launch of this laboratory, Lupin Diagnostics will deliver high-quality and reliable diagnostic services to patients and consumers across Hyderabad and neighbouring cities.

In addition to routine and specialized tests, Lupin Diagnostics offers molecular diagnostics, cytogenetics, flow cytometry, cytology, microbiology, serology, haematology, immunology, routine biochemistry and many more. The team of qualified clinical experts at Lupin Diagnostics leverage state-of-the-art automation and streamlined processes to deliver highly accurate test results. This enables our patients to make informed decisions about their health.

"We are thrilled to continue our mission of providing accessible and affordable quality healthcare to individuals and families in India," said Ravindra Kumar, CEO, Lupin Diagnostics. "Diagnostics test results are crucial for doctors and patients to make informed decisions. Accurate diagnosis is the first step towards managing diseases and identifying the appropriate line of treatment. Our personalized and interactive smart reports can help doctors and patients analyse historical patterns in health parameters and guide treatment options based on evidence," he added.

Lupin Diagnostics provides a comprehensive range of diagnostic services to doctors, patients, and consumers. The company offers several consumer-centric features, such as live home collection booking and tracking, GPS-enabled temperature-controlled sample movement, free home collection, NABL accreditation of each laboratory, smart reports, and trend report analysis.

The company started its journey by establishing a state-of-the-art 45,000 sq. ft. National Reference Laboratory in Navi Mumbai with world-class equipment, experienced doctors assisted by trained technologists and stringent quality control protocols.

Shares of Lupin Limited was last trading in BSE at Rs. 661.30 as compared to the previous close of Rs. 659.20. The total number of shares traded during the day was 8378 in over 815 trades.

The stock hit an intraday high of Rs. 662.75 and intraday low of 650.05. The net turnover during the day was Rs. 5501461.00.

Source : Equity Bulls

Keywords

Lupin INE326A01037 RegionalReferenceLaboratory Hyderabad Telangana